{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T13:54:31Z","timestamp":1785678871068,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.modpat.2023.100324","type":"journal-article","created":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T04:56:51Z","timestamp":1693717011000},"page":"100324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Solid-Basaloid Adenoid Cystic Carcinoma of the Breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression"],"prefix":"10.1016","volume":"36","author":[{"given":"Eliah R.","family":"Shamir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Bean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Vohra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace M.","family":"Allard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Wolsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin J.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunn-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5285-0862","authenticated-orcid":false,"given":"Gregor","family":"Krings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.modpat.2023.100324_bib1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s41379-018-0005-y","article-title":"Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles","volume":"31","author":"Andreasen","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2023.100324_bib2","series-title":"Editorial Board. WHO Classification of Breast Tumours","first-page":"142","article-title":"Adenoid cystic carcinoma","author":"Foschini","year":"2019"},{"issue":"7","key":"10.1016\/j.modpat.2023.100324_bib3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/PAS.0000000000000878","article-title":"MYB labeling by immunohistochemistry is more sensitive and specific for breast adenoid cystic carcinoma than MYB labeling by FISH","volume":"41","author":"Poling","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2023.100324_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/path.4573","article-title":"Genomic landscape of adenoid cystic carcinoma of the breast","volume":"237","author":"Martelotto","year":"2015","journal-title":"J\u00a0Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2023.100324_bib5","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41379-018-0008-8","article-title":"MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts","volume":"31","author":"Togashi","year":"2018","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2023.100324_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/path.5006","article-title":"MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene","volume":"244","author":"Kim","year":"2018","journal-title":"J\u00a0Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2023.100324_bib7","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0046-8177(87)80413-6","article-title":"Adenoid cystic carcinoma of the breast","volume":"18","author":"Ro","year":"1987","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2023.100324_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00000478-200204000-00002","article-title":"Solid variant of mammary adenoid cystic carcinoma with basaloid features: a study of nine cases","volume":"26","author":"Shin","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2023.100324_bib9","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41379-019-0425-3","article-title":"Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations","volume":"33","author":"Mass\u00e9","year":"2020","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2023.100324_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41379-021-00931-6","article-title":"The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features","volume":"35","author":"Schwartz","year":"2022","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2023.100324_bib11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/PAS.0000000000001378","article-title":"Predictors of outcome in mammary adenoid cystic carcinoma: a multi-institutional study","volume":"44","author":"Slodkowska","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2023.100324_bib12","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.humpath.2014.07.013","article-title":"MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features","volume":"45","author":"D\u2019Alfonso","year":"2014","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2023.100324_bib13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/PAS.0000000000001913","article-title":"MYB RNA in situ hybridization is a useful diagnostic tool to distinguish breast adenoid cystic carcinoma from other triple-negative breast carcinomas","volume":"46","author":"Butcher","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2023.100324_bib14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/PAS.0000000000001616","article-title":"MYB RNA in situ hybridization facilitates sensitive and specific diagnosis of adenoid cystic carcinoma regardless of translocation status","volume":"45","author":"Rooper","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2023.100324_bib15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann Oncol"},{"issue":"28","key":"10.1016\/j.modpat.2023.100324_bib16","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","article-title":"Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy","volume":"25","author":"Symmans","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.modpat.2023.100324_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1200\/JOP.18.00206","article-title":"HER2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline focused update summary","volume":"14","author":"Wolff","year":"2018","journal-title":"J\u00a0Oncol Pract"},{"issue":"6","key":"10.1016\/j.modpat.2023.100324_bib18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.5858\/134.6.907","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"134","author":"Hammond","year":"2010","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.modpat.2023.100324_bib19","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41379-019-0449-8","article-title":"Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2\/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma","volume":"33","author":"Shamir","year":"2020","journal-title":"Mod Pathol"},{"issue":"16","key":"10.1016\/j.modpat.2023.100324_bib20","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","article-title":"Sacituzumab Govitecan in metastatic triple-negative breast cancer","volume":"384","author":"Bardia","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.modpat.2023.100324_bib21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.oooo.2015.10.016","article-title":"Clinical utility of myb rearrangement detection and p63\/p40 immunophenotyping in the diagnosis of adenoid cystic carcinoma of minor salivary glands: a pilot study","volume":"121","author":"Argyris","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.modpat.2023.100324_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-pathol-052016-100127","article-title":"The varied roles of Notch in cancer","volume":"12","author":"Aster","year":"2017","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2023.100324_bib23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"269","key":"10.1016\/j.modpat.2023.100324_bib24","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.modpat.2023.100324_bib25","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1200\/PO.20.00175","article-title":"Tumor regression after treatment with lenvatinib in FGFR2-mutated ameloblastoma","volume":"4","author":"Weaver","year":"2020","journal-title":"JCO Precis Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2023.100324_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng.3502","article-title":"An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma","volume":"48","author":"Drier","year":"2016","journal-title":"Nat Genet"},{"issue":"22","key":"10.1016\/j.modpat.2023.100324_bib27","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1158\/1078-0432.CCR-11-1870","article-title":"Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome","volume":"17","author":"Mitani","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"5694","key":"10.1016\/j.modpat.2023.100324_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.modpat.2023.100324_bib29","article-title":"A\u00a0novel SEC22B-NOTCH2 fusion in chronic lymphocytic leukemia","volume":"21","author":"Crotty","year":"2020","journal-title":"Hum Pathol Case Rep"},{"issue":"11","key":"10.1016\/j.modpat.2023.100324_bib30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/gcc.22981","article-title":"CARMN-NOTCH2 fusion transcript drives high NOTCH2 expression in glomus tumors of the upper digestive tract","volume":"60","author":"Girard","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"10.1016\/j.modpat.2023.100324_bib31","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/gcc.22102","article-title":"Novel MIR143-NOTCH fusions in benign and malignant glomus tumors","volume":"52","author":"Mosquera","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"12","key":"10.1016\/j.modpat.2023.100324_bib32","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/nm.2580","article-title":"Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer","volume":"17","author":"Robinson","year":"2011","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.modpat.2023.100324_bib33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1200\/JCO.2016.67.5264","article-title":"Activating NOTCH1 mutations define a distinct subgroup of patients with adenoid cystic carcinoma who have poor prognosis, propensity to bone and liver metastasis, and potential responsiveness to Notch1 inhibitors","volume":"35","author":"Ferrarotto","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.modpat.2023.100324_bib34","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1172\/JCI128227","article-title":"Genetic hallmarks of recurrent\/metastatic adenoid cystic carcinoma","volume":"129","author":"Ho","year":"2019","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.modpat.2023.100324_bib35","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/cdd.2010.37","article-title":"Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates","volume":"17","author":"Yalcin-Ozuysal","year":"2010","journal-title":"Cell Death Differ"},{"issue":"8","key":"10.1016\/j.modpat.2023.100324_bib36","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1101\/gad.1406006","article-title":"Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation","volume":"20","author":"Nguyen","year":"2006","journal-title":"Genes Dev"},{"issue":"7","key":"10.1016\/j.modpat.2023.100324_bib37","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1172\/JCI67201","article-title":"Whole exome sequencing of adenoid cystic carcinoma","volume":"123","author":"Stephens","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.modpat.2023.100324_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.anndiagpath.2007.01.009","article-title":"Basaloid carcinoma of the breast: a review of 9 cases, with delineation of a possible clinicopathologic entity","volume":"12","author":"Lamovec","year":"2008","journal-title":"Ann Diagn Pathol"},{"issue":"7418","key":"10.1016\/j.modpat.2023.100324_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","year":"2012","journal-title":"Nature"},{"issue":"7403","key":"10.1016\/j.modpat.2023.100324_bib40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.modpat.2023.100324_bib41","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1245\/s10434-013-2911-z","article-title":"Rare breast cancer: 933 adenoid cystic carcinomas from the National Cancer Data Base","volume":"20","author":"Kulkarni","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.modpat.2023.100324_bib42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s10637-019-00739-x","article-title":"Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma","volume":"38","author":"Even","year":"2020","journal-title":"Invest New Drugs"},{"issue":"8","key":"10.1016\/j.modpat.2023.100324_bib43","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41419-022-05133-9","article-title":"AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling","volume":"13","author":"Ferrarotto","year":"2022","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.modpat.2023.100324_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41573-020-00091-3","article-title":"Targeting Notch in oncology: the path forward","volume":"20","author":"Majumder","year":"2021","journal-title":"Nat Rev Drug Discov"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223002296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223002296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:26:08Z","timestamp":1760232368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395223002296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0893395223002296"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100324","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solid-Basaloid Adenoid Cystic Carcinoma of the Breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100324"}}